Clinical Trial: A Study of Sequential Therapy With AHB-137 Injection Followed by TVAX-008 Injection in Participants Living With Chronic Hepatitis B (CHB)

U.S., Oct. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07876856) titled 'A Study of Sequential Therapy With AHB-137 Injection Followed by TVAX-008 Injection in Participants Living With Chronic Hepatitis B (CHB)' on Oct. 09.

Brief Summary: This is a study of sequential therapy with AHB-137 injection followed by TVAX-008 injection in participants living with Chronic Hepatitis B (CHB).

Study Start Date: Oct. 31

Study Type: INTERVENTIONAL

Condition: Chronic Hepatitis B

Intervention: DRUG: AHB-137

AHB-137 will be administered per 1 week.

DRUG: Placebo

Placebo will be used per 4 weeks.

DRUG: TVAX-008

TVAV-008 will be administered per 4 weeks.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Ausper ...